The global Cancer therapy market is estimated to grow at 17.6% CAGR to reach $38.2bilÃÃ Ãion by 2019. Breast cancer therapy is the largestmarket expected to reach $26.8 billion by 2015 at an estimated CAGR of 15%.
Rise in cancer incidences and access to modern therapeutics, population of aged people, Increase in innovations, improvements and approvals promote growth of the market. Furthermore, efficiency and High process magnetize manufactures also contribute to the growth of the market .Major restraints are high price of therapies, change in reimbursement policies, and challenges faced in clinical trials.
Market is segmented based on therapies i. e Targeted cancer therapies ( Hormone therapy, Signal transduction inhibitors, gene expression modulators, Apoptosis inducers etc.), Hormone therapies( Forms of hormone therapy) , immunotherapy( Monoclonal antibodies, Cancer vaccines, Non specific immunotherapies) ,Chemotherapy
Based on geography market is segmented into North America (US, Canada), Europe, Asia and Rest of the world. Major players are focusing on marketing their products in emerging markets such as India, Japan, Brazil, and China. Oncology spending remain concentrated to America and Europe which totally accounts for 65% of the total market. Targeted therapies have increased their share of global oncology from 11 percent to 46 percent last year.
Major companies in the market include Dendreon, Galena Biopharma, Newlink genetics, Peregrine pharmaceuticals, Inovio pharmaceuticals.
Players are implementing new innovations, strategies, new product launches to gain a competitive edge.
What makes our report Unique?
1) The report discusses what the market is about, current trends in the market and future forecasts of the market. Market share analysis of various companies based on the product and geography.
2) We give you a longest possible segmentation of the market based on products, applications, type of therapies available and geography.
3) High level analysis of the market size, competitive landscape of major players which include mergers & Acquisitions, collaborations, new product launches, and strategies followed to sustain in the market.
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)